Medicare delays DME payment cuts—but only for four months, and not for rural areas

What it does

This bill delays Medicare payment cuts for durable medical equipment (wheelchairs, oxygen, etc.) in non-competitive bidding areas. It extends a temporary transition rule through the end of 2025 that keeps payment rates higher than they would otherwise be, and blocks a lower payment schedule from taking effect until January 1, 2026. The bill protects suppliers and patients from immediate rate reductions in most of the country.

Why we flagged it

The bill's sole operative mechanism is a temporary extension of higher Medicare reimbursement rates for durable medical equipment suppliers, postponing a scheduled rate reduction by four months. It is a narrow, time-limited payment relief measure.

What the text implies

• The bill does not address the underlying competitive bidding program redesign; it merely delays its financial impact, suggesting the rate reduction will still occur in 2026 unless further legislation intervenes.
• Suppliers in rural and noncontiguous areas are explicitly excluded from the transition-rule extension in subsection (a), creating a two-tier system where rural DME providers face earlier rate reductions.
• The four-month delay may allow suppliers time to lobby for permanent relief or to adjust operations, but provides no structural solution to payment sustainability.
• Patients dependent on DME may face service disruptions or supplier exits after January 1, 2026, if the lower rates prove uneconomical for providers.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Patients and suppliers benefit from maintained payment rates and service continuity in the short term. However, the bill delays rather than resolves underlying payment pressure, and the eventual 2026 rate reduction may still harm access or affordability; the civic benefit is temporary and the long-term cost structure remains unaddressed.

Who stands to gain

• durable medical equipment suppliers and manufacturers
• DME rental and sales companies

Named in the bill

Secretary of Health and Human Services, Medicare, DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) program, 42 CFR 414.210(g)(9)(v), 42 CFR 414.210(g)(9)(vi)

Where it stands

3 cosponsors: 2 Republicans, 1 Democrats.

• Sep 30, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Sep 30, 2025 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

7 lobbying clients named this bill on 12 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,280,000 in lobbying spend. A filing names 6 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 86% of bills with at least one filing.

James Lankford, the sponsor, reported $368,500 in PAC receipts in the 2026 cycle.

• American Association for Homecare — $800,000 on 2 filings
• Accendra Health Inc. — $740,000 on 3 filings
• Medline — $400,000 on 1 filing
• American Association for Homecare (aahomecare) — $140,000 on 2 filings
• American Association for Homecare (aahomecare) — $120,000 on 2 filings

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.